Symbiosis IP expands intellectual property and patent services

2023-11-28

高管变更

Patent attorney business Symbiosis IP has expanded its intellectual property (IP) and patent services following the appointment of IP licensing and commercialisation specialists Dr Amy Lam and Dr Andrew Tingey. Amy Lam, who joins as associate director – Consulting & IP transactions, and Andrew Tingey, who joins as director – Licensing & IP transactions, will complement Symbiosis IP’s existing specialisms within patent protection and life sciences to support clients in understanding, leveraging, and realising the value of their IP. Combined with the IP and commercial teams at Gateley, the professional services business that acquired Symbiosis IP, and Adamson Jones, another patent and trade mark attorney business within Gateley, Lam and Tingey can help provide comprehensive, end-to-end commercial, IP valuation, and licensing strategy services to clients across a range of sectors, including life sciences, chemicals, and fintech. “I’m pleased to welcome Amy and Andrew, who bring a combined 40 years’ experience in IP licensing and commercialisation,” said Symbiosis IP director Rob Docherty. “Their appointments will enhance the existing services provided by Symbiosis IP, Adamson Jones, and Gateley’s legal business, Gateley Legal, to support clients in realising the full commercial value of their IP.” Previously a principal consultant and head of the Scotland office at Wellspring, Lam specialises in IP management and strategy, business development, and early-stage commercialisation across life sciences, and has experience supporting IP commercialisation in other sectors, such as software-as-a-service (SaaS). She led on and supported more than 120 life science consulting projects for public and private sector clients, covering innovations such as pharmaceuticals, genome editing, cell therapy, and medical diagnostics. “Clients often understand the need for IP within their operations, without appreciating its potential to expand and enhance the value of their inventions,” Lam said. “Symbiosis and Gateley recognised that there is a gap in the market for a truly comprehensive service that covers all aspects of IP, from its identification to patent protection and commercialisation. I’m looking forward to working with Andrew and the wider team to build this service and provide added value to clients.” Andrew Tingey, who also joins Symbiosis IP from Wellspring, is an experienced dealmaker who has led on, and been involved in, hundreds of commercial agreements involving the licensing and sale of IP rights across life sciences, Greentech, chemicals, and software. Recently nominated in the IAM300 Group for ‘Global leaders in IP strategy’, Andrew has worked with large corporates, SMEs, venture capital firms, and technology transfer offices, and has advised on in and out licensing strategies, complex negotiations and IP valuation projects. During his career, Andrew has been involved in several hundred licensing transactions and the formation of over 60 start-up companies. “Many of the clients that I encounter appreciate how to use IP defensively, but they don’t always understand the art of the possible in terms of releasing the value of that IP,” Tingey said. “Working with the patent attorneys at Symbiosis IP and Adamson Jones, as well as the IP and commercial specialists at Gateley Legal, I hope to flip clients’ thinking so that they see IP, less as an expense, and more as a tool to extend a business’s geographical reach and income potential.”

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构